Coach Mpilo app for men with TB and HIV
Part of Infections clinical trials.
This study tests a coaching app (Coach Mpilo) to help men in South Africa who are starting or restarting TB treatment, and for those who also have HIV but are not yet on HIV medication. The goal is to see if the app is helpful and usable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older.
- You are starting TB treatment for the first time or restarting it after being lost from care.
- You live in the Buffalo City Metro (BCM) Health District in South Africa.
- If you join the HIV part of the study, you must be HIV-positive and not currently taking HIV medications (ART).
- You are willing to provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to improve TB prevention in rural and semi-urban clinics in South Africa. They will work with clinic staff and district leaders to find better ways to stop TB.
This study tests whether regular support from a peer (someone who is also living with HIV and doing well) can help men get back into HIV care and stay on treatment. It is designed for men who have missed their HIV clinic appointment by more than a month and are not currently on antiretroviral therapy (ART).
This study tests a smartphone program to help young men who have sex with men stay healthy and prevent HIV. It's designed for people already getting care at certain clinics.
This study tests a new way of talking to people living with HIV about 'Undetectable = Untransmittable' (U=U) — meaning when HIV medicine makes the virus undetectable, it cannot be passed to others. It aims to make HIV counseling more helpful and supportive for people in South Africa.
This study is testing a program to help people who are living with HIV and TB to stop smoking. It aims to see if quitting smoking improves their engagement with HIV and TB care.
This study tests whether special “U=U” style messages can improve how men move from HIV testing to starting treatment and continuing care. You may be asked to receive guidance and information meant to help you stay engaged in HIV treatment.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.